Sharing-our-perspective-page-header2



Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward


  • Pharmacy Resource Guide 2018

    by
    • Optum Workers' Comp
    | Dec 05, 2018
    Tag Icon
    Opioids, Workers' Compensation, Pharmacy, Morphine Equivalent Dose, Medication Safety, Medication Plans, Medication Analysis
    Our latest Pharmacy Resource Guide identifies our Top 10 therapeutic classes; our Top 25 medications as a percentage of total spend, number of prescriptions and generic spend; plus latest trends from NCCI and a Brand-Generic Index of commonly-used workers’ compensation medications.


  • Lyrica® generic delayed until summer 2019 and Pfizer to increase drug prices

    by
    • Optum
    | Nov 29, 2018
    Tag Icon
    Workers' Compensation, Pharmacy, Clinical
    The U.S. Food and Drug Administration extended the period of market exclusivity for Lyrica® for six months, delaying the Lyrica generic. And Pfizer plans to increase prices. Read more on our blog.


  • FDA approves new opioid analgesic - Dsuvia™ (sufentanil sublingual tablet)

    by
    • Optum Workers' Comp
    | Nov 06, 2018
    Tag Icon
    Pain Management, Opioids, FDA, Clinical
    On November 2, 2018, the U.S. Food and Drug Administration (FDA) approved the first and only sufentanil sublingual (under-the-tongue) tablet for acute pain in healthcare settings, Dsuvia (sufentanil sublingual tablet, 30 mcg).


  • Medication trends shaping workers' compensation

    by
    • Optum Workers' Comp
    | Nov 01, 2018
    Tag Icon
    Workers' Compensation, Analytics
    A review of the medication trends shaping workers’ compensation, gathered from our book of business data during the first half of 2018.




Do you have a question for our
Government Affairs team?






Subscribe

Stay informed by signing up to receive our latest update. *Denotes a required field